468 related articles for article (PubMed ID: 19222739)
1. Anaemia and mineral bone disorder in chronic kidney disease: a review of the current literature and implications for clinical nursing practice.
Limrick C; McNichols-Thomas C
J Ren Care; 2009 Mar; 35 Suppl 1():94-100. PubMed ID: 19222739
[TBL] [Abstract][Full Text] [Related]
2. CE: Continuing Education article. Patient management in CKD stages 1 TO 3.
Murphy F; Jenkins K; Chamney M; McCann M; Sedgewick J
J Ren Care; 2008 Sep; 34(3):127-35. PubMed ID: 18786079
[TBL] [Abstract][Full Text] [Related]
3. Chronic kidney disease and cardiovascular disease--using the ANNA Standards and Practice Guidelines to improve care. Part 1: the epidemiology of chronic kidney disease: the risk factors and complications that contribute to cardiovascular disease.
McCarley PB; Burrows-Hudson S
Nephrol Nurs J; 2006; 33(6):666-74; quiz 675-6. PubMed ID: 17219728
[TBL] [Abstract][Full Text] [Related]
4. Updating practices in an evolving IV iron and anemia environment: practical solutions.
Amerling R; Easom A; Juergensen P
Nephrol Nurs J; 2007; 34(5):533-41; quiz 542-3. PubMed ID: 18041456
[TBL] [Abstract][Full Text] [Related]
5. The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease.
Singh AK; Hertello P
Nephrol Nurs J; 2005; 32(2):199-206; quiz 207-8. PubMed ID: 15889804
[TBL] [Abstract][Full Text] [Related]
6. Management of anemia in chronic kidney disease (predialysis) patients: nephrology nursing implications.
Wish JB; Weigel KA
Nephrol Nurs J; 2001 Jun; 28(3):341-5. PubMed ID: 12143456
[TBL] [Abstract][Full Text] [Related]
7. Creating a better environment to treat anemia in patients with CKD.
Sinnen MT
Nephrol Nurs J; 2007; 34(6):645-9. PubMed ID: 18203573
[No Abstract] [Full Text] [Related]
8. Revisions in the prescribing information for Epoetin alfa: implications for nephrology nurses and patients on dialysis.
Hayslip D
Nephrol Nurs J; 2008; 35(2):163-7. PubMed ID: 18472685
[TBL] [Abstract][Full Text] [Related]
9. Management of mineral and bone disorders in patients on dialysis: a team approach to improving outcomes.
Carver M; Carder J; Hartwell L; Arjomand M
Nephrol Nurs J; 2008; 35(3):265-70. PubMed ID: 18649587
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease/bone and mineral metabolism: the imperfect storm.
Williams ME
Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800
[TBL] [Abstract][Full Text] [Related]
11. Early initiation of phosphate lowering dietary therapy in non-dialysis chronic kidney disease: a critical review.
Sigrist MK; Chiarelli G; Lim L; Levin A
J Ren Care; 2009 Mar; 35 Suppl 1():71-8. PubMed ID: 19222735
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified.
Ix JH; Quarles LD; Chertow GM
Nat Clin Pract Nephrol; 2006 Jun; 2(6):337-9. PubMed ID: 16932455
[TBL] [Abstract][Full Text] [Related]
13. ORAMA: a study to investigate EBPG impact on renal anaemia - design and baseline data.
Locatelli F; Covic A; Macdougall IC; Wiecek A;
J Nephrol; 2008; 21(4):592-603. PubMed ID: 18651551
[TBL] [Abstract][Full Text] [Related]
14. Management of co-morbid diseases in a patient with established renal failure.
Chamney M; Pugh-Clarke K; Kafkia T
J Ren Care; 2009 Sep; 35(3):151-8. PubMed ID: 19689698
[TBL] [Abstract][Full Text] [Related]
15. A review of anemia management in the oncology setting: a focus on implementing standing orders.
Mickle J; Reinke D
Clin J Oncol Nurs; 2007 Aug; 11(4):534-9. PubMed ID: 17723966
[TBL] [Abstract][Full Text] [Related]
16. New EORTC guidelines for the treatment of anaemia in patients with cancer: implications for nursing practice.
Foubert J
Eur J Oncol Nurs; 2006 Jul; 10(3):177-86. PubMed ID: 16199202
[TBL] [Abstract][Full Text] [Related]
17. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overview.
Bailie GR; Massry SG;
Pharmacotherapy; 2005 Dec; 25(12):1687-707. PubMed ID: 16305288
[TBL] [Abstract][Full Text] [Related]
18. Anemia and cardiovascular risk in the patient with kidney disease.
Fishbane S
Heart Fail Clin; 2008 Oct; 4(4):401-10. PubMed ID: 18760752
[TBL] [Abstract][Full Text] [Related]
19. Optimizing anemia management in hospitalized patients with end-stage renal disease.
Heung M; Mueller BA; Segal JH
Ann Pharmacother; 2009 Feb; 43(2):276-82. PubMed ID: 19141655
[TBL] [Abstract][Full Text] [Related]
20. Uremic syndrome and end-stage renal disease: physical manifestations and beyond.
Chikotas N; Gunderman A; Oman T
J Am Acad Nurse Pract; 2006 May; 18(5):195-202. PubMed ID: 16681706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
